Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why equity is still not completely measurable in clinical trials, what proper representation in studies is, and how certain demographics are at a disadvantage for biomarker tests compared to other groups with host Deborah Borfitz. Their conversation explores whether health equity in cancer trials is different compared to c...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Scope of Things
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems
Get summaries like this every morning.
Free AI-powered recaps of The Scope of Things and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.